Novartis

Novartis touts mid-stage results for MenB

admin — Thu, 15 May 2008 06:59:57 -0400

Novartis says that a mid-stage study of its MenB vaccine demonstrated broad protection from meningococcal B infections in infants. Researchers tracked positive results starting with three Read more...

Novartis opens non-profit R&D vaccine center

admin — Thu, 28 Feb 2008 06:59:58 -0500

One of the world's biggest pharma companies is breaking its business mold for its new R&D center for vaccines. Novartis is modeling its new vaccine development center in Italy on the Novartis Read more...

Novartis to offer data on pre-pandemic jabs

admin — Thu, 28 Feb 2008 06:59:57 -0500

Novartis hasn't given up in its pursuit of profits. The Swiss company has been making an argument for use of its experimental flu vaccine ahead of any potential outbreak. Vaccines chief Jörg Read more...

Gene-mapping unlocks new generation of vaccines

admin — Thu, 20 Dec 2007 06:59:58 -0500

Researchers at Novartis have made significant headway using gene-mapping tools to develop Read more...